NDC 46287-045

TADLIQ

Tadalafil

TADLIQ is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Cmp Pharma, Inc.. The primary component is Tadalafil.

• Product ID: 46287-045_184d37e8-dadf-442c-b025-d7e02183da04
• NDC: 46287-045
• Product Type: Human Prescription Drug
• Proprietary Name: TADLIQ
• Generic Name: Tadalafil
• Dosage Form: Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2022-08-30
• Marketing Category: NDA /
• Application Number: NDA214522
• Labeler Name: CMP Pharma, Inc.
• Substance Name: TADALAFIL
• Active Ingredient Strength: 20 mg/5mL
• Pharm Classes: Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 46287-045-15

150 mL in 1 BOTTLE (46287-045-15)

• Marketing Start Date: 2022-08-30
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "TADLIQ" or generic name "Tadalafil"

NDC	Brand Name	Generic Name
0093-3334	ALYQ	Tadalafil
0002-4462	Cialis	Tadalafil
0002-4463	Cialis	Tadalafil
0002-4464	Cialis	Tadalafil
0002-4465	Cialis	Tadalafil
0093-3016	Tadalafil	Tadalafil
0093-3017	Tadalafil	Tadalafil
0093-3018	Tadalafil	Tadalafil
0093-3019	Tadalafil	Tadalafil